AB018. Evaluation of nivolumab as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC)

Por Nikolakopoulou, Asimina, Tzimopoulos, Kon/nos, Kerasiotis, Haralambos, Kallianos, Anastasios, Kavvada, Catherine, Gkartzonika, Helen, Tsarouha, Emilia, Rapti, Angeliki
Publicado no Ann Transl Med (2016)